KWS: Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented
What it covers
A shoulder joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a shoulder joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a humeral resurfacing component made of alloys, such as cobalt-chromium-molybdenum, and a glenoid resurfacing component made of ultra-high molecular weight polyethylene, and is limited to those prostheses intended for use with bone cement (§ 888.3027).
The identification in 21 CFR 888.3660, shoulder joint metal/polymer semi-constrained cemented prosthesis. FDA gives KWS no definition of its own, so the regulation’s describes it.
FDA flags KWS devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260721 | Tornier Perform Advanced Glenoid | Tornier, Inc. | Jul 22, 2026 | Traditional |
| K254084 | AETOS Shoulder System - CONCELOC Glenoids | Smith & Nephew, Inc. | Apr 6, 2026 | Traditional |
| K252418 | Catalyst F1x Shoulder System | Catalyst Orthoscience, Inc. | Nov 6, 2025 | Traditional |
| K252416 | AETOS Shoulder System Meta Humeral Prosthesis Size 0 | Smith & Nephew, Inc. | Oct 29, 2025 | Traditional |
| K241292 | MyShoulder Planner (5.3SSWPL) | Medacta International S.A. | Jan 30, 2025 | Traditional |
| K241878 | Tornier Humeral Reconstruction System (Tornier HRS); Tornier Perform Humeral System - Stem (Tornier PHS-Stem) | Stryker Corporation (Tornier, Inc.) | Dec 6, 2024 | Traditional |
| K241609 | Tornier Humeral Reconstruction System (Tornier HRS) | Stryker Corporation (Tornier, Inc.) | Sep 10, 2024 | Traditional |
| K230513 | Arthrex Univers Apex OptiFit Humeral Stem | Arthrex, Inc. | Sep 26, 2023 | Traditional |
| K222592 | AltiVate® Anatomic Shoulder AG e+ with Markers | Encore Medical L.P. | Jun 23, 2023 | Abbreviated |
| K230572 | AETOS Shoulder System | Smith & Nephew, Inc. | Jun 7, 2023 | Traditional |
Clearances by year
99 KWS 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 2 | 124 |
| 2025 | 3 | 97 |
| 2024 | 2 | 129 |
| 2023 | 4 | 250 |
| 2022 | 5 | 158 |
| 2021 | 5 | 151 |
| 2020 | 3 | 98 |
| 2019 | 9 | 106 |
| 2018 | 4 | 152 |
| 2017 | 7 | 120 |
| 2016 | 10 | 114 |
| 2015 | 8 | 129 |
| 2014 | 7 | 89 |
| 2013 | 12 | 120 |
| 2012 | 7 | 86 |
| 2011 | 11 | 90 |
Who submits
32 applicants cleared a KWS device since 2011. 77% of the clearances went to applicants in United States, then France (8%), Belgium (5%) and Switzerland (5%). By type: Traditional 73%, Special 26% and Abbreviated 1%.
| Applicant | Clearances since 2011 |
|---|---|
| Arthrex, Inc. | 10 |
| Tornier, Inc. | 10 |
| Encore Medical L.P. | 8 |
| Lima Corporate S.P.A. | 8 |
| Tornier S.A.S. | 8 |
| Smith & Nephew, Inc. | 6 |
| Exactech, Inc. | 5 |
| Materialise NV | 5 |
How FDA classifies it
Class II. The special controls for this device are:
(1) FDA's:
(i) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Devices—Part I: Evaluation and Testing,’ ”
(ii) “510(k) Sterility Review Guidance of 2/12/90 (K90-1),”
(iii) “Guidance Document for Testing Orthopedic Implants with Modified Metallic Surfaces Apposing Bone or Bone Cement,”
(iv) “Guidance Document for the Preparation of Premarket Notification (510(k)) Application for Orthopedic Devices,” and
(v) “Guidance Document for Testing Non-articulating, ‘Mechanically Locked’ Modular Implant Components,”
(2) International Organization for Standardization's (ISO):
(i) ISO 5832-3:1996 “Implants for Surgery—Metallic Materials—Part 3: Wrought Titanium 6-aluminum 4-vandium Alloy,”
(ii) ISO 5832-4:1996 “Implants for Surgery—Metallic Materials—Part 4: Cobalt-chromium-molybdenum casting alloy,”
(iii) ISO 5832-12:1996 “Implants for Surgery—Metallic Materials—Part 12: Wrought Cobalt-chromium-molybdenum alloy,”
(iv) ISO 5833:1992 “Implants for Surgery—Acrylic Resin Cements,”
(v) ISO 5834-2:1998 “Implants for Surgery—Ultra-high Molecular Weight Polyethylene—Part 2: Moulded Forms,”
(vi) ISO 6018:1987 “Orthopaedic Implants—General Requirements for Marking, Packaging, and Labeling,” and
(vii) ISO 9001:1994 “Quality Systems—Model for Quality Assurance in Design/Development, Production, Installation, and Servicing,” and
(3) American Society for Testing and Materials':
(i) F 75-92 “Specification for Cast Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implant Material,”
(ii) F 648-98 “Specification for Ultra-High-Molecular-Weight Polyethylene Powder and Fabricated Form for Surgical Implants,”
(iii) F 799-96 “Specification for Cobalt-28 Chromium-6 Molybdenum Alloy Forgings for Surgical Implants,”
(iv) F 1044-95 “Test Method for Shear Testing of Porous Metal Coatings,”
(v) F 1108-97 “Specification for Titanium-6 Aluminum-4 Vanadium Alloy Castings for Surgical Implants,”
(vi) F 1147-95 “Test Method for Tension Testing of Porous Metal,”
(vii) F 1378-97 “Standard Specification for Shoulder Prosthesis,” and
(viii) F 1537-94 “Specification for Wrought Cobalt-28 Chromium-6 Molybdenum Alloy for Surgical Implants.”
From 21 CFR 888.3660. Special controls are the requirements a 510(k) must show it meets.
Standards
21 CFR 888.3660 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent KWS clearances declared.
Ask about KWS
Questions about KWS
What is FDA product code KWS?
Product code KWS, “Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented” in FDA's classification database, is a Class II device type under 21 CFR 888.3660 (shoulder joint metal/polymer semi-constrained cemented prosthesis), reviewed by FDA's Orthopedic panel. FDA's 510(k) database lists 191 clearances under KWS, 99 of them since 2011.
How many 510(k) clearances are there under KWS?
FDA’s 510(k) database listed 191 clearances under KWS as of Oct 29, 2026, 99 of them decided since 2011; the most recent decision was Jul 22, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a KWS 510(k)?
For the 6 KWS clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 124 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most KWS clearances?
Since 2011: Arthrex, Inc. (10), Tornier, Inc. (10), Encore Medical L.P. (8), Lima Corporate S.P.A. (8) and Tornier S.A.S. (8). 32 applicants have cleared a KWS device in that time.